Detalhe da pesquisa
1.
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.
Am J Perinatol;
37(4): 421-429, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30991438
2.
SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.
Am J Perinatol;
34(1): 51-61, 2017 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27233106
3.
Receipt of palivizumab before birth hospitalization discharge among preterm infants in the United States.
Am J Perinatol;
32(11): 1017-23, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25877742
4.
Impact of Respiratory Syncytial Virus-Confirmed Hospitalizations on Caregivers of US Preterm Infants.
Clin Pediatr (Phila);
58(8): 837-850, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31007050
5.
Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product.
PLoS One;
14(11): e0224700, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31697731
6.
The Logistics and Coordination of Respiratory Syncytial Virus Immunoprophylaxis Use Among US Pediatric Specialists.
Clin Pediatr (Phila);
55(13): 1230-1241, 2016 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26746004
7.
Perceived Risk of Severe Respiratory Syncytial Virus Disease and Immunoprophylaxis Use Among US Pediatric Specialists.
Clin Pediatr (Phila);
55(8): 724-37, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26400767
8.
A population-weighted, condition-adjusted estimate of palivizumab efficacy in preventing RSV-related hospitalizations among US high-risk children.
Hum Vaccin Immunother;
10(10): 2785-8, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25483483
9.
Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants.
Hum Vaccin Immunother;
10(10): 2789-94, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25483663
10.
Respiratory syncytial virus surveillance in the United States, 2007-2012: results from a national surveillance system.
Pediatr Infect Dis J;
33(6): 589-94, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24445835
11.
Laboratory testing trends for respiratory syncytial virus, 2007-2011.
J Clin Virol;
58(3): 575-8, 2013 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24103492